iterativehealth

Director, Site Performance & Solutions (Cardiology)

Apply Now

At a Glance

Location
Cambridge, Massachusetts, United States, New York, New York, United States
Experience
10+ years
Posted
2026-05-06T12:36:07-04:00

Key Requirements

Domain Knowledge

  • Clinical

Requirements

10+ years of clinical research experience

Demonstrated proficiency with clinical research systems and tools, including CTMS and pre-screening workflows

Proven people management experience, with a track record of leading, developing, and holding accountable clinical research teams

Prior experience in a director-level or senior management role within a site network, CRO, or health tech organization

Cardiology-specific clinical research experience

At Iterative Health, we’re actively working towards creating an environment that is representative of the diversity of patients our technology serves.

Responsibilities

As the Director, Site Performance & Solutions (Cardiology), you will report to the VP, Growth and serve as the owner of Iterative Health's central clinical services that are delivered to our cardiology research sites as performance-enabling solutions, including pre-screening, regulatory support, and eSource.

Your mandate is to oversee, optimize, and continuously improve these service offerings so that our sites enroll faster, operate better, and achieve stronger trial outcomes

Network Performance Ownership

Serve as the single accountable owner for trial performance across IH's cardiology site network

Monitor site and network-level performance metrics continuously, identifying trends, gaps, and risks before they escalate

Service Deployment & Performance Improvement

About the Company

Iterative Health is a healthcare technology and services company powering the acceleration of clinical research to transform patient outcomes. The Iterative Health Site Network is a premier network of 100+ clinical research sites across the US and Europe, accelerating the path to market for novel therapies. By combining deep expertise in clinical trials with cutting-edge AI, we empower research teams and study sponsors to expand and expedite access to novel therapeutics for patients in need.